Search
Search Results
##search.searchResults.foundPlural##
-
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3481PDF: 1051HTML: 3032 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3882PDF: 980HTML: 6890 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4623PDF: 1838HTML: 1131 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1614PDF: 1027HTML: 267 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1751HTML: 715PDF: 931 -
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2049PDF: 1121HTML: 265 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1872PDF: 868HTML: 312 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1599PDF: 869HTML: 377 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2149PDF: 2013HTML: 813
1 - 16 of 16 items







